MDxHealth SA (MDXH) Misses Q4 EPS by 4c, maintains guidance

MDxHealth SA (NASDAQ: MDXH) reported Q4 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $30.29 million.

GUIDANCE:

MDxHealth SA sees FY2026 revenue of $137-140 million, versus the consensus of $135.7 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• ACM Research, Inc. (ACMR) PT Raised to $130 at Morgan Stanley
• Zuckerberg Directed Meta To Create Prediction Markets App - NYT